(Date:12/2/2008)... Need to Reduce Disparities in Meningococcal Vacci...THESDA, Md., Dec. 2 The National....P. (Share. Teach. Outreach. Protect.) Meningiti...ading medical and advocacy organizations, recently...ingococcal vaccination rates and to reduce immuniz...
(Date:12/2/2008)...le to seniors , , DETROIT, Dec. 2 /PRNewswi...dding acupuncture and chiropractic services to its...ntage members beginning January 1, 2009. HAP,s gro...es Medicare beneficiaries to choose activities and...heir wallets. , , HAP offers a Flexible He...
(Date:12/2/2008)...y with no additional radiation, minimal cost , ...orectal cancer and osteoporosis are very different...tely detect, a new study says. , A virtual colo...s in the large intestine. A presentation, expected...g of the Radiological Society of North America, wi...
(Date:12/2/2008)...developed a prototype blood scanner that can find ...of the disease, potentially allowing for earlier t...ival. , The system based on MagArray biodetectio...lood serum sample in less than an hour, and with m...evices. In fact, the device, which uses magnetic n...
Breaking Medicine News(10 mins):Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services 2Health News:HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services 3Health News:CT Colonography Screens for Cancer, Osteoporosis 2Health News:Stanford blood scanner detects even faint indicators of cancer 2Health News:Stanford blood scanner detects even faint indicators of cancer 3...ska, sharing some winter skincare tips would help ...For those of us in Europe and the US, winter can b.... The experts say you should always use a mild, su...u spend in the bath or shower to no more than ten ...
...vere periodontal disease than non-diabetic pregnan...riodontology.// Researchers from the University of...13 type 1 diabetic and 20 non-diabetic women in th...ine the effects of periodontal infection on the co...
...ersity students, and there is significant incidenc...rcing,"// said Dr. Lester B. Mayers of the Pace Un...Medicine and the lead author of the study. A surv...s revealed that more than one-half had some type o...
...roducts more than twice a week can obviously reduc...nsuming cooked tomatoes was particularly beneficia...arly eating tomato sauce, ketchup and other tomato...er risk by as much as 30 percent.// Dr. Edward Gio...
Other Medicine News:(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/25/2008)...ewswire-FirstCall/ -- CardioVascular,BioTherapeut...day that it has,dosed the first patient in North ...al trial to treat patients with severe coronary he...tment of CORonary heart Disease) trial will includ...ed doses in approximately 120,patients with sever...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
(Date:11/24/2008)...Cancer Awareness Month , , Oak Brook, Ill.,...Society for Gastrointestinal Endoscopy (ASGE) and ...p this November to raise awareness about pancreati... the resources that are available for them. , ... of cancer deaths in the U.S. In 2008, an estimate...
Breaking Medicine Technology:Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 1AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 2AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 3AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 4Houston Heart Surgeon Elected Vice President of Guatemala 5534 1Houston Heart Surgeon Elected Vice President of Guatemala 5534 2Fragile X Foundations Sign Merger Agreement 5532 1Fragile X Foundations Sign Merger Agreement 5532 2Fragile X Foundations Sign Merger Agreement 5532 3Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 1Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 2...at the Movement Disorder Society,s 11th,Internatio..., June 08, 2007 /PRNewswire-FirstCall/ -- New,info...ts) for the,treatment of Parkinson,s disease (PD) ...ciety,s congress in Istanbul, Turkey.,Once-daily A...he,treatment of the signs and symptoms of PD, both...
....--(BUSINESS WIRE)--Jun 8, 2007 - AVANIR,Pharmaceu...ion of,Phase III data, including efficacy, safety ...atients with diabetic peripheral,neuropathic (DPN)...(TM) (dextromethorphan/quinidine (DM/Q)), an NMDA ...were accepted as,late-breakers, and presented in ...
Other Medicine Technology:International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 2International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 3International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 5International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 4AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 5AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 7For the quantitative measurement of CKMB, Myoglobin, and Troponin-I in human serum.
According to the National Academy of Clinical Biochemistry guidelines for the use of cardiac markers in coronary artery disease, troponin I is definitive of acute myocardial infarction. The new Acces
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che
Clinical marker immunoassay kit for detection of Myoglobin.
Medicine Products: